Ann Alcasid

Affiliations

Pfizer Inc, Collegeville, PA, USA.

Publications (5)

Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Avec: Jocelyn Courville , Loretta Nastoupil , Nitin Kaila , John Kelton , Jeffrey Zhang , Ann Alcasid , Pilar Nava-Parada

A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Avec: Jeff P Sharman , Anna Marina Liberati , Kenichi Ishizawa , Tahira Khan , Jeffery Robbins , Ann Alcasid , Julie Ann Rosenberg , Igor Aurer

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.

Future oncology (London, England)

Avec: Gregory J Riely , Egbert F Smit , Myung-Ju Ahn , Enriqueta Felip , Suresh S Ramalingam , Anne Tsao , Melissa Johnson , Francesco Gelsomino , Raymond Esper , Ernest Nadal , Michael Offin , Mariano Provencio , Jeffrey Clarke , Maen Hussein , Gregory A Otterson , Ibiayi Dagogo-Jack , Jonathan W Goldman , Daniel Morgensztern , Ann Alcasid , Tiziana Usari , Paul Wissel , Keith Wilner , Nuzhat Pathan , Svitlana Tonkovyd , Bruce E Johnson

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Avec: Gregory J Riely , Egbert F Smit , Myung-Ju Ahn , Enriqueta Felip , Suresh S Ramalingam , Anne Tsao , Melissa Johnson , Francesco Gelsomino , Raymond Esper , Ernest Nadal , Michael Offin , Mariano Provencio , Jeffrey Clarke , Maen Hussain , Gregory A Otterson , Ibiayi Dagogo-Jack , Jonathan W Goldman , Daniel Morgensztern , Ann Alcasid , Tiziana Usari , Paul Wissel , Keith Wilner , Nuzhat Pathan , Svitlana Tonkovyd , Bruce E Johnson

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.

BMC cancer

Avec: Elena Elez , Antonio Cubillo , Pilar Garcia Alfonso , Mark R Middleton , Ian Chau , Baha Alkuzweny , Ann Alcasid , Xiaosong Zhang , Eric Van Cutsem

Réseau de co-auteurs

Gregory J Riely 2 collaborations

Egbert F Smit 2 collaborations

Myung-Ju Ahn 2 collaborations

Enriqueta Felip 2 collaborations

Suresh S Ramalingam 2 collaborations

Anne Tsao 2 collaborations

Melissa Johnson 2 collaborations

Francesco Gelsomino 2 collaborations

Raymond Esper 2 collaborations

Ernest Nadal 2 collaborations

Michael Offin 2 collaborations

Mariano Provencio 2 collaborations

Jeffrey Clarke 2 collaborations

Gregory A Otterson 2 collaborations

Ibiayi Dagogo-Jack 2 collaborations

Jonathan W Goldman 2 collaborations

Daniel Morgensztern 2 collaborations

Tiziana Usari 2 collaborations

Paul Wissel 2 collaborations

Keith Wilner 2 collaborations

Nuzhat Pathan 2 collaborations

Svitlana Tonkovyd 2 collaborations

Bruce E Johnson 2 collaborations

Jocelyn Courville 1 collaboration

Loretta Nastoupil 1 collaboration

Nitin Kaila 1 collaboration

John Kelton 1 collaboration

Jeffrey Zhang 1 collaboration

Pilar Nava-Parada 1 collaboration

Jeff P Sharman 1 collaboration

Anna Marina Liberati 1 collaboration

Kenichi Ishizawa 1 collaboration

Tahira Khan 1 collaboration

Jeffery Robbins 1 collaboration

Julie Ann Rosenberg 1 collaboration

Igor Aurer 1 collaboration

Maen Hussein 1 collaboration

Maen Hussain 1 collaboration

Elena Elez 1 collaboration

Antonio Cubillo 1 collaboration

Pilar Garcia Alfonso 1 collaboration

Mark R Middleton 1 collaboration

Ian Chau 1 collaboration

Baha Alkuzweny 1 collaboration

Xiaosong Zhang 1 collaboration

Eric Van Cutsem 1 collaboration